Lenalidomide N-Aminopropanoyl Impurity

Request For Quotation
Lenalidomide N-Aminopropanoyl Impurity Suppliers list
Company Name: Daicel Chiral Technologies (China)CO.,LTD  
Tel: 021-50460086-9 15921403865
Email: han_yajun@dctc.daicel.com
Company Name: Jilin Province Woda Biotechnology Co., Ltd.  
Tel: 13504435624
Email: 1927928688@qq.com
Company Name: ShenZhen Trendseen Biological Technology Co.,Ltd.  
Tel: 13417589054
Email: trendseenbio@gmail.com
Lenalidomide N-Aminopropanoyl Impurity Basic information
Product Name:Lenalidomide N-Aminopropanoyl Impurity
Synonyms:Lenalidomide N-Aminopropanoyl Impurity;Propanamide, 3-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-;3-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Propanamide,;3-Amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]propanamide (ACI);Lenalidomide-CO-C2-NH2;3-amino-N-[2-(2,6-dioxopiperidin-3-yl)-1-oxo-2,3-dihydro-1H-isoindol-4-yl]propanamide
CAS:1407590-76-4
MF:C16H18N4O4
MW:330.34
EINECS:
Product Categories:
Mol File:1407590-76-4.mol
Lenalidomide N-Aminopropanoyl Impurity Structure
Lenalidomide N-Aminopropanoyl Impurity Chemical Properties
Boiling point 718.6±60.0 °C(Predicted)
density 1.445±0.06 g/cm3(Predicted)
pka10.69±0.40(Predicted)
Safety Information
MSDS Information
Lenalidomide N-Aminopropanoyl Impurity Usage And Synthesis
Lenalidomide N-Aminopropanoyl Impurity Preparation Products And Raw materials
Tag:Lenalidomide N-Aminopropanoyl Impurity(1407590-76-4) Related Product Information
3-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Propanamide, hydrochloride 3-amino-1-methylpiperidine-2,6-dione hydrochloride 3-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Propanamide, hydrochloride 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]amino]-8-oxoOctanoic acid, β-Alanine, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]- 5-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Pentanamide, 6-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]amino]-6-oxoHexanoic acid, Lenalidomide 8-amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)octanamide 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]amino]-7-oxoHeptanoic acid, 4-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Butanamide 6-amino-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hexanamide 7-amino-N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-Heptanamide, 11-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]amino]-11-oxoUndecanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]amino]-4-oxo-Butanoic acid Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]amino]-5-oxo-